This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

WWHC Stock Overview

W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. More details

WWHC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($235K)

Shares are highly illiquid

Latest financial reports are more than a year old

My Notes

Capture your thoughts, links and company narrative

W World Corp. Competitors

Molecular Templates

OTCPK:MTEM

US$17.1k

NexImmune

OTCPK:NEXI

US$138.1k

Histogen

OTCPK:HSTO.Q

US$115.3k

Allena Pharmaceuticals

OTCPK:ALNA.Q

US$109.9k

Price History & Performance

Summary of share price highs, lows and changes for W World
Historical stock prices
Current Share Price	US$0.80
52 Week High	US$2.00
52 Week Low	US$0.50
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	-35.80%
3 Year Change	-73.33%
5 Year Change	-74.19%
Change since IPO	-99.99%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	WWHC	US Biotechs	US Market
7D	0%	-0.2%	3.2%
1Y	-35.8%	-7.0%	24.2%

Return vs Industry: WWHC underperformed the US Biotechs industry which returned 10.3% over the past year.

Return vs Market: WWHC underperformed the US Market which returned 24.4% over the past year.

Price Volatility

Is WWHC's price volatile compared to industry and market?
WWHC volatility
WWHC Average Weekly Movement	n/a
Biotechs Industry Average Movement	11.2%
Market Average Movement	6.5%
10% most volatile stocks in US Market	18.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: WWHC has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine WWHC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1990	n/a	n/a	www.pharmoscorp.com

W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent, which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome.

W World Corp. Fundamentals Summary

How do W World's earnings and revenue compare to its market cap?
WWHC fundamental statistics
Market cap	US$234.99k
Earnings (TTM)	-US$1.72m
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is WWHC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
WWHC income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$1.72m
Earnings	-US$1.72m

Last Reported Earnings

Sep 30, 2012

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did WWHC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/03/03 13:33
End of Day Share Price	2023/12/05 00:00
Earnings	2012/09/30
Annual Earnings	2011/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

W World Corp. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution